The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland

  1. Aleksander D Szymaniak
  2. Rongjuan Mi
  3. Shannon E McCarthy
  4. Adam C Gower
  5. Taylor L Reynolds
  6. Michael Mingueneau
  7. Maria Kukuruzinska
  8. Xaralabos Varelas  Is a corresponding author
  1. Boston University School of Medicine, United States
  2. Biogen, United States
  3. Boston University School of Dental Medicine, United States

Abstract

Salivary glands, such as submandibular glands (SMGs), are composed of branched epithelial ductal networks that terminate in acini that together produce, transport and secrete saliva. Here, we show that the transcriptional regulator Yap, a key effector of the Hippo pathway, is required for the proper patterning and morphogenesis of SMG epithelium. Epithelial deletion of Yap in developing SMGs results in the loss of ductal structures, arising from reduced expression of the EGF family member Epiregulin, which we show is required for the expansion of Krt5/Krt14-positive ductal progenitors. We further show that epithelial deletion of the Lats1 and Lats2 genes, which encode kinases that restrict nuclear Yap localization, results in morphogenesis defects accompanied by an expansion of Krt5/Krt14-positive cells. Collectively, our data indicate that Yap-induced Epiregulin signaling promotes the identity of SMG ductal progenitors and that removal of nuclear Yap by Lats1/2-mediated signaling is critical for proper ductal maturation.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Aleksander D Szymaniak

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  2. Rongjuan Mi

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  3. Shannon E McCarthy

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  4. Adam C Gower

    Boston University Clinical and Translational Science Institute, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  5. Taylor L Reynolds

    Immunology Research, Biogen, Cambridge, United States
    Competing interests
    Taylor L Reynolds, Employee of Biogen.
  6. Michael Mingueneau

    Immunology Research, Biogen, Cambridge, United States
    Competing interests
    Michael Mingueneau, Employee of Biogen.
  7. Maria Kukuruzinska

    Department of Molecular and Cell Biology, Boston University School of Dental Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  8. Xaralabos Varelas

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    For correspondence
    xvarelas@bu.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2882-4541

Funding

March of Dimes Foundation (1-FY14-219)

  • Xaralabos Varelas

National Heart, Lung, and Blood Institute (R01 HL124392)

  • Xaralabos Varelas

Sjogren's Syndrome Foundation (Research Grant)

  • Xaralabos Varelas

National Institute of Dental and Craniofacial Research (R21 DE024954)

  • Maria Kukuruzinska

National Center for Advancing Translational Sciences (UL1-TR001430)

  • Adam C Gower
  • Xaralabos Varelas

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.Animal care and handling was consistent with the recommendations of the Panel on Euthanasia of the American Veterinary Medical Association. Prior to the initiation of experiments, all study protocols were reviewed and modified according to the suggestions of the Boston University School of Medicine IACUC. The Boston University School of Medicine animal management program is accredited by the American Association for the Accreditation of Laboratory Animal Care, and meets National Institutes of Health standards as set forth in the Guide for the Care and Use of Laboratory Animals (DHHS Pub.No. (NIH) 85-23, rev 1985). Boston University's Animal Welfare Assurance number is A-3316-01.

Copyright

© 2017, Szymaniak et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,237
    views
  • 509
    downloads
  • 41
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Aleksander D Szymaniak
  2. Rongjuan Mi
  3. Shannon E McCarthy
  4. Adam C Gower
  5. Taylor L Reynolds
  6. Michael Mingueneau
  7. Maria Kukuruzinska
  8. Xaralabos Varelas
(2017)
The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland
eLife 6:e23499.
https://doi.org/10.7554/eLife.23499

Share this article

https://doi.org/10.7554/eLife.23499

Further reading

    1. Developmental Biology
    Wei Yan
    Editorial

    The articles in this special issue highlight the diversity and complexity of research into reproductive health, including the need for a better understanding of the fundamental biology of reproduction and for new treatments for a range of reproductive disorders.

    1. Developmental Biology
    Anastasiia Lozovska, Ana Casaca ... Moises Mallo
    Research Article

    During the trunk to tail transition the mammalian embryo builds the outlets for the intestinal and urogenital tracts, lays down the primordia for the hindlimb and external genitalia, and switches from the epiblast/primitive streak (PS) to the tail bud as the driver of axial extension. Genetic and molecular data indicate that Tgfbr1 is a key regulator of the trunk to tail transition. Tgfbr1 has been shown to control the switch of the neuromesodermal competent cells from the epiblast to the chordoneural hinge to generate the tail bud. We now show that in mouse embryos Tgfbr1 signaling also controls the remodeling of the lateral plate mesoderm (LPM) and of the embryonic endoderm associated with the trunk to tail transition. In the absence of Tgfbr1, the two LPM layers do not converge at the end of the trunk, extending instead as separate layers until the caudal embryonic extremity, and failing to activate markers of primordia for the hindlimb and external genitalia. The vascular remodeling involving the dorsal aorta and the umbilical artery leading to the connection between embryonic and extraembryonic circulation was also affected in the Tgfbr1 mutant embryos. Similar alterations in the LPM and vascular system were also observed in Isl1 null mutants, indicating that this factor acts in the regulatory cascade downstream of Tgfbr1 in LPM-derived tissues. In addition, in the absence of Tgfbr1 the embryonic endoderm fails to expand to form the endodermal cloaca and to extend posteriorly to generate the tail gut. We present evidence suggesting that the remodeling activity of Tgfbr1 in the LPM and endoderm results from the control of the posterior PS fate after its regression during the trunk to tail transition. Our data, together with previously reported observations, place Tgfbr1 at the top of the regulatory processes controlling the trunk to tail transition.